The distribution of placental oxidoreductase isoforms provides different milieus of steroids influencing pregnancy in the maternal and fetal compartment

Hormone Molecular Biology and Clinical Investigation

Volumn 4, Issue 3, 2010, Pages 581-600

  Hill, Martin ^a,b   Velíková1, Marta ^a   Kubátová1, Jana ^a   Kancheva1, Radmila ^a   Dušková1, Michaela ^a   šimunková, Kateřina ^a   Stárka, Luboslav ^a   Klímková, Michaela ^b   Pašková, Andrea ^b   žižka, Zdeněk ^b   Pařízek, Antonín ^b   Jirásek, Jan Evangelista ^c   Jirkovská, Marie ^d  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE FOR THE CARE OF MOTHER AND CHILD   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

estrogens; neuroactive steroids; oxidoreductases; placenta; progestogens

Indexed keywords

EID: 85000002504     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/HMBCI.2010.077     Document Type: Article

References (88)

1. Mathur RS., Landgrebe S., Williamson HO. Progesterone., 17-hydroxyprogesterone, estradiol., and estriol in late pregnancy and labor. Am J Obstet Gynecol 1980;136:25-7.
2. Hercz P., Ungar L., Siklos P. Perinatal progesterone in maternal-fetoplacental system during mature and premature deliveries. Acta Obstet Gynecol Scand 1988;67:233-5.
3. Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig 2004;11: 193-202.
4. Karalis K., Goodwin G., Majzoub JA. Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor. Nat Med 1996;2:556-60.
5. Majewska MD., Vaupel DB. Steroid control of uterine motility via gamma-aminobutyric acidA receptors in the rabbit: a novel mechanism? J Endocrinol 1991;131:427-34.
6. Majewska MD. Steroid regulation of the GABAA receptor: ligand binding., chloride transport and behaviour. Ciba Found Symp 1990;153:83-97; discussion-106.
7. Koksma JJ., van Kesteren RE., Rosahl TW., Zwart R., Smit AB., Luddens H., Brussaard AB. Oxytocin regulates neurosteroid modulation of GABA(A) receptors in supraoptic nucleus around parturition. J Neurosci 2003;23:788-97.
8. Hill M., Cibula D., Havlikova H., Kancheva L., Fait T., Kancheva R., Parizek A., Starka L. Circulating levels of pregnanolone iso-mers during the third trimester of human pregnancy. J Steroid Biochem Mol Biol 2007;105:166-75.
9. Havlikova H., Hill M., Kancheva L., Vrbikova J., Pouzar V., Cerny I., Kancheva R., Starka L. Serum profiles of free and conjugated neuroactive pregnanolone isomers in nonpregnant women of fertile age. J Clin Endocrinol Metab 2006;91:3092-9.
10. Weaver CE., Land MB., Purdy RH., Richards KG., Gibbs TT., Farb DH. Geometry and charge determine pharmacological effects of steroids on N-methyl-D-aspartate receptor-induced Ca(2 + ) accumulation and cell death. J Pharmacol Exp Ther 2000;293:747-54.
11. Rune GM., Frotscher M. Neurosteroid synthesis in the hippocampus: role in synaptic plasticity. Neuroscience 2005;136: 833-42.
12. Wang MD., Wahlstrom G., Backstrom T. The regional brain distribution of the neurosteroids pregnenolone and pregnenolone sulfate following intravenous infusion. J Steroid Biochem Mol Biol 1997;62:299-306.
13. Yoshihara S., Morimoto H., Ohori M., Yamada Y., Abe T., Arisaka O. A neuroactive steroid., allotetrahydrocorticosterone inhibits sensory nerves activation in guinea-pig airways. Neurosci Res 2005;53:210-5.
14. Knock GA., Tribe RM., Hassoni AA., Aaronson PI. Modulation of potassium current characteristics in human myometrial smooth muscle by 17beta-estradiol and progesterone. Biol Reprod 2001;64:1526-34.
15. Todorovic SM., Pathirathna S., Brimelow BC., Jagodic MM., Ko SH., Jiang X., Nilsson KR., Zorumski CF., Covey DF., Jevtovic-Todorovic V. 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2q channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo. Mol Pharmacol 2004;66:1223-35.
16. Milewich L., Gant NF., Schwarz BE., Prough RA., Chen GT., Athey B., Macdonald PC. Initiation of human parturition. VI. Identification and quantification of progesterone metabolites produced by the components of human fetal membranes. J Clin Endocrinol Metab 1977;45:400-11.
17. Dombroski RA., Casey ML., MacDonald PC. 5-Alpha-dihydro-progesterone formation in human placenta from 5alpha-pre-gnan-3beta/alpha-ol-20-ones and 5-pregnan-3beta-yl-20-one sulfate. J Steroid Biochem Mol Biol 1997;63:155-63.
18. Mickan H., Zander J. Pregnanolones., pregnenolone and progesterone in the human feto-placental circulation at term of pregnancy. J Steroid Biochem 1979;11:1461-6.
19. Meng LJ., Reyes H., Axelson M., Palma J., Hernandez I., Ribalta J., Sjovall J. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Hepatology 1997;26:1573-9.
20. Hill M., Parizek A., Bicikova M., Havlikova H., Klak J., Fait T., Cibula D., Hampl R., Cegan A., Sulcova J., Starka L. Neuroactive steroids., their precursors., and polar conjugates during parturition and postpartum in maternal and umbilical blood: 1. identification and simultaneous determination of pregnanolone isomers. J Steroid Biochem Mol Biol 2000;75:237-44.
21. Gilbert Evans SE., Ross LE., Sellers EM., Purdy RH., Romach MK. 3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period. Gynecol Endo-crinol 2005;21:268-79.
22. Pearson Murphy BE., Steinberg SI., Hu FY., Allison CM. Neu-roactive ring A-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5 alpha-dihydro-progesterone in depressed patients during the latter half of pregnancy. J Clin Endocrinol Metab 2001;86:5981-7.
23. Putnam CD., Brann DW., Kolbeck RC., Mahesh VB. Inhibition of uterine contractility by progesterone and progesterone metabolites: mediation by progesterone and gamma amino butyric acidA receptor systems. Biol Reprod 1991;45:266-72.
24. Penning TM., Burczynski ME., Jez JM., Hung CF., Lin HK., Ma H., Moore M., Palackal N., Ratnam K. Human 3alpha-hydroxy-steroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 2000;351:67-77.
25. Park-Chung M., Malayev A., Purdy RH., Gibbs TT., Farb DH. Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites. Brain Res 1999;830:72-87.
26. Moghrabi N., Head JR., Andersson S. Cell type-specific expression of 17 beta-hydroxysteroid dehydrogenase type 2 in human placenta and fetal liver. J Clin Endocrinol Metab 1997;82: 3872-8.
27. Lin SX., Shi R., Qiu W., Azzi A., Zhu DW., Dabbagh HA., Zhou M. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5. Mol Cell Endocrinol 2006;248:38-46.
28. Peltoketo H., Nokelainen P., Piao YS., Vihko R., Vihko P. Two 17beta-hydroxysteroid dehydrogenases (17HSDs) of estradiol biosynthesis: 17HSD type 1 and type 7. J Steroid Biochem Mol Biol 1999;69:431-9.
29. Penning TM., Burczynski ME., Jez JM., Lin HK., Ma H., Moore M., Ratnam K., Palackal N. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3). Mol Cell Endocrinol 2001;171:137-149.
30. Li Y., Isomaa V., Pulkka A., Herva R., Peltoketo H., Vihko P. Expression of 3beta-hydroxysteroid dehydrogenase type 1, P450 aromatase., and 17beta-hydroxysteroid dehydrogenase types 1, 2, 5 and 7 mRNAs in human early and mid-gestation placentas. Placenta 2005;26:387-392.
31. Sakurai N., Miki Y., Suzuki T., Watanabe K., Narita T., Ando K., Yung TM., Aoki D., Sasano H., Handa H. Systemic distribution and tissue localizations of human 17beta-hydroxysteroid dehy-drogenase type 12. J Steroid Biochem Mol Biol 2006;99: 174-81.
32. Bonenfant M., Provost PR., Drolet R., Tremblay Y. Localization of type 1 17beta-hydroxysteroid dehydrogenase mRNA and protein in syncytiotrophoblasts and invasive cytotrophoblasts in the human term villi. J Endocrinol 2000;165:217-222.
33. Takeyama J., Sasano H., Suzuki T., Iinuma K., Nagura H., Ander-sson S. 17Beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta: an immunohistochemical study with correlation to placental development. J Clin Endocrinol Metab 1998; 83:3710-5.
34. Bonenfant M., Blomquist CH., Provost PR., Drolet R., D'Ascoli P., Tremblay Y. Tissue- and site-specific gene expression of type 2 17beta-hydroxysteroid dehydrogenase: in situ hybridization and specific enzymatic activity studies in human placental endothelial cells of the arterial system. J Clin Endocrinol Metab 2000;85:4841-4850.
35. Lukacik P., Keller B., Bunkoczi G., Kavanagh KL., Lee WH., Adamski J., Oppermann U. Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity. Biochem J 2007;402:419-27.
36. Lundgren P., Stromberg J., Backstrom T., Wang M. Allopregna-nolone-stimulated GABA-mediated chloride ion flux is inhibited by 3beta-hydroxy-5alpha-pregnan-20-one (isoallopreg-nanolone). Brain Res 2003;982:45-53.
37. Belelli D., Lambert JJ., Peters JA., Gee KW., Lan NC. Modulation of human recombinant GABAA receptors by pregnanediols. Neuropharmacology 1996;35:1223-31.
38. Hill M., Parizek A., Cibula D., Kancheva R., Jirasek JE., Jirkovska M., Velikova M., Kubatova J., Klimkova M., Paskova A., Zizka Z., Kancheva L., Kazihnitkova H., Zamrazilova L., Starka L. Steroid metabolome in fetal and maternal body fluids in human late pregnancy. J Steroid Biochem Mol Biol 2010;122:114-32.
39. Milewich L., Gant NF., Schwarz BE., Chen GT., Macdonald PC. Initiation of human parturition. IX. Progesterone metabolism by placentas of early and late human gestation. Obstet Gynecol 1978;51:278-80.
40. Diaz-Zagoya JC., Wiest WG., Arias F. 20 alpha-Hydroxysteroid oxidoreductase activity and 20 alpha-dihydroprogesterone concentration in human placenta before and after parturition. Am J Obstet Gynecol 1979;133:673-6.
41. Mitchell BF., Wong S. Changes in 17beta,20alpha-hydroxyste-roid dehydrogenase activity supporting an increase in the estrogen/progesterone ratio of human fetal membranes at parturition. Am J Obstet Gynecol 1993;168:1377-85.
42. Shiraishi H., Ishikura S., Matsuura K., Deyashiki Y., Ninomiya M., Sakai S., Hara A. Sequence of the cDNA of a human dihydrodiol dehydrogenase isoform (AKR1C2) and tissue distribution of its mRNA. Biochem J 1998;334(Pt 2):399-405.
43. Jin Y., Duan L., Lee SH., Kloosterboer HJ., Blair IA., Penning TM. Human cytosolic hydroxysteroid dehydrogenases of the aldo-ketoreductase superfamily catalyze reduction of conjugated steroids: implications for phase I and phase II steroid hormone metabolism. J Biol Chem 2009;284:10013-22.
44. Penning TM. Molecular determinants of steroid recognition and catalysis in aldo-keto reductases. Lessons from 3alpha-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 1999;69:211-25.
45. Steckelbroeck S., Jin Y., Gopishetty S., Oyesanmi B., Penning TM. Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J Biol Chem 2004;279:10784-95.
46. Usami N., Yamamoto T., Shintani S., Ishikura S., Higaki Y., Kata-giri Y., Hara A. Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines. Biol Pharm Bull 2002;25: 441-5.
47. Jin Y., Stayrook SE., Albert RH., Palackal NT., Penning TM., Lewis M. Crystal structure of human type III 3alpha-hydroxy-steroid dehydrogenase/bile acid binding protein complexed with NADP( + ) and ursodeoxycholate. Biochemistry 2001;40: 10161-8.
48. Nishizawa M., Nakajima T., Yasuda K., Kanzaki H., Sasaguri Y., Watanabe K., Ito S. Close kinship of human 20alpha-hydroxy-steroid dehydrogenase gene with three aldo-keto reductase genes. Genes Cells 2000;5:111-25.
49. Penning TM., Jin Y., Steckelbroeck S., Lanisnik Rizner T., Lewis M. Structure-function of human 3 alpha-hydroxysteroid dehy-drogenases: genes and proteins. Mol Cell Endocrinol 2004; 215:63-72.
50. Krazeisen A., Breitling R., Imai K., Fritz S., Moller G., Adamski J. Determination of cDNA., gene structure and chromosomal localization of the novel human 17beta-hydroxysteroid dehy-drogenase type 7(1). FEBS Lett 1999;460:373-9.
51. Torn S., Nokelainen P., Kurkela R., Pulkka A., Menjivar M., Ghosh S., Coca-Prados M., Peltoketo H., Isomaa V., Vihko P. Production., purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochem Biophys Res Commun 2003;305:37-45.
52. Huang XF., Luu-The V. Molecular characterization of a first human 3(alpha->beta)-hydroxysteroid epimerase. J Biol Chem 2000;275:29452-7.
53. He XY., Merz G., Yang YZ., Mehta P., Schulz H., Yang SY. Characterization and localization of human type10 17beta-hydroxy-steroid dehydrogenase. Eur J Biochem 2001;268:4899-907.
54. He XY., Yang YZ., Peehl DM., Lauderdale A., Schulz H., Yang SY. Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 2003;87:191-198.
55. Shafqat N., Marschall HU., Filling C., Nordling E., Wu XQ., Bjork L., Thyberg J., Martensson E., Salim S., Jornvall H., Oppermann U. Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/ 17beta/20beta/21-HSD. Biochem J 2003;376:49-60.
56. Brereton P., Suzuki T., Sasano H., Li K., Duarte C., Obeyesekere V., Haeseleer F., Palczewski K., Smith I., Komesaroff P., Kro-zowski Z. Pan1b (17betaHSD11)-enzymatic activity and distribution in the lung. Mol Cell Endocrinol 2001;171:111-7.
57. Chai Z., Brereton P., Suzuki T., Sasano H., Obeyesekere V., Escher G., Saffery R., Fuller P., Enriquez C., Krozowski Z. 17 beta-hydroxysteroid dehydrogenase type XI localizes to human ste-roidogenic cells. Endocrinology 2003;144:2084-91.
58. Hill M., Parizek A., Jirasek JE., Jirkovska M., Velikova M., Dus-kova M., Klimkova M., Paskova A., Zizka Z., Germanova A., Koucky M., Kalousova M., Starka L. Is maternal progesterone actually independent of the fetal steroids? Physiol Res 2010; 59:211-24.
59. Hill M., Parizek A., Kancheva R., Duskova M., Velikova M., Kriz L., Klimkova M., Paskova A., Zizka Z., Matucha P., Meloun M., Starka L. Steroid metabolome in plasma from the umbilical artery., umbilical vein., maternal cubital vein and in amniotic fluid in normal and preterm labor. J Steroid Biochem Mol Biol 2010;121:594-610.
60. Schuetz JD., Kauma S., Guzelian PS. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. J Clin Invest 1993;92:1018-24.
61. Wang H., Ping J., Peng RX., Yue J., Xia XY., Li QX., Kong R., Hong JY. Changes of multiple biotransformation phase I and phase II enzyme activities in human fetal adrenals during fetal development. Acta Pharmacol Sin 2008;29:231-8.
62. Lacroix D., Sonnier M., Moncion A., Cheron G., Cresteil T. Expression of CYP3A in the human liver-evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 1997;247:625-34.
63. Tahara R., Yanaihara T., Araki H., Nakayama T. Steroid concentrations in human cervical tissue in relation to cervical ripening. Nippon Sanka Fujinka Gakkai Zasshi 1985;37:1924-30.
64. Milewich L., Gant NF., Schwarz BE., Chen GT., MacDonald PC. Initiation of human parturition. VIII. Metabolism of progesterone by fetal membranes of early and late human gestation. Obstet Gynecol 1977;50:45-8.
65. Andersson S., Minjarez D., Yost NP., Word RA. Estrogen and progesterone metabolism in the cervix during pregnancy and parturition. J Clin Endocrinol Metab 2008;93:2366-74.
66. Buster JE., Chang RJ., Preston DL., Elashoff RM., Cousins LM., Abraham GE., Hobel CJ., Marshall JR. Interrelationships of circulating maternal steroid concentrations in third trimester pregnancies. II. C18 and C19 steroids: estradiol., estriol, dehydroepiandrosterone., dehydroepiandrosterone sulfate., delta
67. androstenediol, delta androstenedione, testosterone., and dihydrotestosterone. J Clin Endocrinol Metab 1979;48:139-42.
68. Turnbull AC., Patten PT., Flint AP., Keirse MJ., Jeremy JY., Anderson AB. Significant fall in progesterone and rise in oes-tradiol levels in human peripheral plasma before onset of labour. Lancet 1974;i:101-3.
69. Parizek A., Hill M., Kancheva R., Havlikova H., Kancheva L., Cindr J., Paskova A., Pouzar V., Cerny I., Drbohlav P., Hajek Z., Starka L. Neuroactive pregnanolone isomers during pregnancy. J Clin Endocrinol Metab 2005;90:395-403.
70. Melamed M., Castano E., Notides AC., Sasson S. Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol. Mol Endocrinol 1997;11:1868-78.
71. Concas A., Follesa P., Barbaccia ML., Purdy RH., Biggio G. Physiological modulation of GABA(A) receptor plasticity by progesterone metabolites. Eur J Pharmacol 1999;375:225-35.
72. Mostallino MC., Sanna E., Concas A., Biggio G., Follesa P. Plasticity and function of extrasynaptic GABA(A) receptors during pregnancy and after delivery. Psychoneuroendocrinology 2009;34(Suppl 1):S74-83.
73. Turkmen S., Lofgren M., Birzniece V., Backstrom T., Johansson IM. Tolerance development to Morris water maze test impairments induced by acute allopregnanolone. Neuroscience 2006; 139:651-9.
74. Maguire J., Ferando I., Simonsen C., Mody I. Excitability changes related to GABAA receptor plasticity during pregnancy. J Neurosci 2009;29:9592-601.
75. Mellor DJ., Diesch TJ., Gunn AJ., Bennet L. The importance of 'awareness' for understanding fetal pain. Brain Res Brain Res Rev 2005;49:455-71.
76. Malayev A., Gibbs TT., Farb DH. Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br J Pharmacol 2002;135:901-9.
77. Park-Chung M., Wu FS., Purdy RH., Malayev AA., Gibbs TT., Farb DH. Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids. Mol Pharmacol 1997; 52:1113-23.
78. Kussius CL., Kaur N., Popescu GK. Pregnanolone sulfate promotes desensitization of activated NMDA receptors. J Neurosci 2009;29:6819-27.
79. Pak CW., Curras-Collazo MC. Expression and plasticity of glu-tamate receptors in the supraoptic nucleus of the hypothalamus. Microsc Res Tech 2002;56:92-100.
80. Antonipillai I., Murphy BE. Serum oestrogens and progesterone in mother and infant at delivery. Br J Obstet Gynaecol 1977;84: 179-85.
81. Shaxted EJ., Heyes VM., Walker MP., Maynard PV. Umbilical-cord plasma progesterone in term infants delivered by caesarean section. Br J Obstet Gynaecol 1982;89:73-6.
82. Lockhart EM., Warner DS., Pearlstein RD., Penning DH., Meh-rabani S., Boustany RM. Allopregnanolone attenuates N-meth-yl-D-aspartate-induced excitotoxicity and apoptosis in the human NT2 cell line in culture. Neurosci Lett 2002;328: 33-6.
83. Crossley KJ., Nitsos I., Walker DW., Lawrence AJ., Beart PM., Hirst JJ. Steroid-sensitive GABAA receptors in the fetal sheep brain. Neuropharmacology 2003;45:461-72.
84. Yawno T., Hirst JJ., Castillo-Melendez M., Walker DW. Role of neurosteroids in regulating cell death and proliferation in the late gestation fetal brain. Neuroscience 2009;163:838-47.
85. Hirst JJ., Yawno T., Nguyen P., Walker DW. Stress in pregnancy activates neurosteroid production in the fetal brain. Neuroen-docrinology 2006;84:264-74.
86. Lofgren M., Holst J., Backstrom T. Effects in vitro of progesterone and two 5 alpha-reduced progestins., 5 alpha-pregnane-3,20-dione and 5 alpha-pregnane-3 alpha-ol-20-one, on contracting human myometrium at term. Acta Obstet Gynecol Scand 1992;71:28-33.
87. Fujii E., Mellon SH. Regulation of uterine gamma-aminobutyric acid(A) receptor subunit expression throughout pregnancy. Endocrinology 2001;142:1770-7.
88. Hidalgo A., Suzano RC., Revuelta MP., Sanchez-Diaz C., Baa-monde A., Cantabrana B. Calcium and depolarization-dependent effect of pregnenolone derivatives on uterine smooth muscle. Gen Pharmacol 1996;27:879-85.